Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Prestige Consumer Heathcare beats Q2 revenue expectations, tightens FY forecast

Overview

Prestige Q2 revenue of $274.1 mln beats analyst expectations despite a 3.4% decline yr/yr

Adjusted EPS of $1.07 for Q2 beats analyst estimates

Company repurchased 1.1 mln shares in Q2, enhancing shareholder value

Outlook

Prestige maintains fiscal 2026 revenue outlook at $1,100 mln to $1,115 mln

Company tightens fiscal 2026 adjusted EPS outlook to $4.54 to $4.58

Prestige expects fiscal 2026 free cash flow of $245 mln or more

Result Drivers

SUPPLY TIMING - Clear Eyes supply timing and retailer order timing helped surpass sales and earnings expectations

LIMITED SUPPLY - Revenue decline driven by limited ability to supply demand for Clear Eyes in Ear & Eye Care category

BRAND-BUILDING - Focus on brand-building and maintaining financial profile contributed to robust free cash flow

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 RevenueBeat$274.11 mln$257.13 mln (7 Analysts)
Q2 Adjusted EPSBeat$1.07$0.97 (7 Analysts)
Q2 Net Income$42.21 mln
Q2 Gross Profit$151.58 mln
Q2 Operating Expenses$71.91 mln
Q2 Operating Income$79.67 mln
Q2 Pretax Profit$69.13 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell" The average consensus recommendation for the pharmaceuticals peer group is "buy" Wall Street's median 12-month price target for Prestige Consumer Healthcare Inc is $80.00, about 25.2% above its November 5 closing price of $59.83 The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 15 three months ago Press Release: ID:nGNX27sbzP For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Prestige Consumer Healthcare

See all news